According to the Zhitong Finance App, Haohai Biotechnology (06826) announced that on July 20, 2026, the company spent about HK$2,6396 million to repurchase 161,000 shares at a repurchase price of HK$16.14 to HK$16.85 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.